164 related articles for article (PubMed ID: 656283)
1. Enhanced elimination of warfarin during treatment with cholestyramine.
Jähnchen E; Meinertz T; Gilfrich HJ; Kersting F; Groth U
Br J Clin Pharmacol; 1978 May; 5(5):437-40. PubMed ID: 656283
[TBL] [Abstract][Full Text] [Related]
2. Interruption of the enterohepatic circulation of phenprocoumon by cholestyramine.
Meinertz T; Gilfrich HJ; Groth U; Jonen HG; Jähnchen E
Clin Pharmacol Ther; 1977 Jun; 21(6):731-5. PubMed ID: 862312
[TBL] [Abstract][Full Text] [Related]
3. Acceleration of the elimination of tenoxicam by cholestyramine in the dog.
Guentert TW; Schmitt M; Defoin R
J Pharmacol Exp Ther; 1986 Jul; 238(1):295-301. PubMed ID: 3723402
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics of coumarin anticoagulants XXIX: Elimination kinetics and anticoagulant activity of (S)-(-)-warfarin in rats before and after chronic administration.
Yacobi A; Levy G
J Pharm Sci; 1977 Sep; 66(9):1275-7. PubMed ID: 903865
[TBL] [Abstract][Full Text] [Related]
5. The influence of cholestyramine on the elimination of tenoxicam and piroxicam.
Guentert TW; Defoin R; Mosberg H
Eur J Clin Pharmacol; 1988; 34(3):283-9. PubMed ID: 3260866
[TBL] [Abstract][Full Text] [Related]
6. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.
Yacobi A; Udall JA; Levy G
Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):552-8. PubMed ID: 1277711
[TBL] [Abstract][Full Text] [Related]
7. Short-term treatment with cholestyramine increases long-acting anticoagulant rodenticide clearance from rabbits without affecting plasma vitamin K1 levels or blood coagulation.
Muchiri RN; Rocha J; Tandon A; Chen YL; Alemani R; Ahmad I; McDonald Z; Lindeblad M; Rubinstein I; van Breemen RB; Feinstein DL
Toxicol Sci; 2024 Jun; 200(1):137-145. PubMed ID: 38603617
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.
Yacobi A; Wingard LB; Levy G
J Pharm Sci; 1974 Jun; 63(6):868-72. PubMed ID: 4851098
[No Abstract] [Full Text] [Related]
9. Diarrhea-associated over-anticoagulation in a patient taking warfarin: therapeutic role of cholestyramine.
Roberge RJ; Rao P; Miske GR; Riley TJ
Vet Hum Toxicol; 2000 Dec; 42(6):351-3. PubMed ID: 11111942
[TBL] [Abstract][Full Text] [Related]
10. Norfloxacin does not alter warfarin's disposition or anticoagulant effect.
Rocci ML; Vlasses PH; Distlerath LM; Gregg MH; Wheeler SC; Zing W; Bjornsson TD
J Clin Pharmacol; 1990 Aug; 30(8):728-32. PubMed ID: 2401751
[TBL] [Abstract][Full Text] [Related]
11. Interaction of warfarin and nonsystemic gastrointestinal drugs.
Robinson DS; Benjamin DM; McCormack JJ
Clin Pharmacol Ther; 1971; 12(3):491-5. PubMed ID: 5567801
[No Abstract] [Full Text] [Related]
12. Determination of kinetic parameters for prothrombin complex activity during initiation of anticoagulation.
Kuranari M; Hara M; Saikawa T; Kodama Y; Matsuo H; Sakata T; Takeyama M
J Clin Pharm Ther; 1997; 22(5-6):347-51. PubMed ID: 19160719
[TBL] [Abstract][Full Text] [Related]
13. Influence of cholestyramine resin administration on single dose sulindac pharmacokinetics.
Malloy MJ; Ravis WR; Pennell AT; Hagan DR; Betagari S; Doshi DH
Int J Clin Pharmacol Ther; 1994 Jun; 32(6):286-9. PubMed ID: 7921528
[TBL] [Abstract][Full Text] [Related]
14. Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose or warfarin.
Slattery JT; Levy G; Jain A; McMahon FG
Clin Pharmacol Ther; 1979 Jan; 25(1):51-60. PubMed ID: 758243
[TBL] [Abstract][Full Text] [Related]
15. Cholestyramine and spironolactone and their combination in digitoxin elimination.
Carruthers SG; Dujovne CA
Clin Pharmacol Ther; 1980 Feb; 27(2):184-7. PubMed ID: 7353337
[TBL] [Abstract][Full Text] [Related]
16. [Acceleration of amiodarone elimination by cholestyramine].
Nitsch J; Lüderitz B
Dtsch Med Wochenschr; 1986 Aug; 111(33):1241-4. PubMed ID: 3743429
[TBL] [Abstract][Full Text] [Related]
17. Alteration of warfarin kinetics in man associated with exposure to an operating-room environment.
Ghoneim MM; Delle M; Wilson WR; Ambre JJ
Anesthesiology; 1975 Sep; 43(3):333-6. PubMed ID: 1163833
[TBL] [Abstract][Full Text] [Related]
18. Cimetidine: interaction with oral anticoagulants in man.
Serlin MJ; Sibeon RG; Mossman S; Breckenridge AM; Williams JR; Atwood JL; Willoughby JM
Lancet; 1979 Aug; 2(8138):317-9. PubMed ID: 89387
[TBL] [Abstract][Full Text] [Related]
19. Interaction between warfarin and propranolol.
Scott AK; Park BK; Breckenridge AM
Br J Clin Pharmacol; 1984 May; 17(5):559-64. PubMed ID: 6733003
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of warfarin at steady state.
Routledge PA; Chapman PH; Davies DM; Rawlins MD
Br J Clin Pharmacol; 1979 Sep; 8(3):243-7. PubMed ID: 497091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
